Skip to content
New: the dataset now includes 2,277 company profiles and every supplied review record. See the methodology →
◎ RankGlobal mapped
PhaseV logo

PhaseV

Predictive Analytics1 Broadway, Cambridge, MAFounded 2023

PhaseV provides AI-driven solutions to optimize clinical-trial development, using predictive models and adaptive trial designs to forecast outcomes and accelerate efficient decision-making for biopharma sponsors.

4.9
Average rating
11
Mapped reviews
100%
Profile coverage

Company & commercials

Primary category
Predictive Analytics
Team size
1-10 employees
Typical budget
$25K - $75K
Primary industry
Healthcare & Life Sciences
Provider overview

A clear view of what PhaseV does best.

Structured from supplied company information and mapped to RankGlobal's controlled AI and industry taxonomy.

Company profile
Predictive Analytics provider for Healthcare & Life Sciences

PhaseV provides AI-driven solutions to optimize clinical-trial development, using predictive models and adaptive trial designs to forecast outcomes and accelerate efficient decision-making for biopharma sponsors. RankGlobal maps its primary capability to Causal Inference within Predictive Analytics, with supporting relevance to Optimization & Decisioning, Predictive Analytics. Its strongest supplied industry signals align with HealthTech Platforms.

See how this profile was mapped →
Primary AI category
Predictive Analytics
Strongest industry signal
Healthcare & Life Sciences
Engagement profile·$25K - $75K·1-10 employees·Service
Mapped capabilities · 1 category
Technology

Platforms, methods and technical signals

Adaptive trial designPredictive modelingMulti-modal AI/ML platform

Tools and platforms named in PhaseV's supplied company profile.

Expertise

Named expertise on file

  • AI‑powered Trial Optimizer

    Machine learning and simulation engine that evaluates millions of adaptive, Bayesian, and fixed trial designs to optimize clinical trial protocols, reduce sample size, costs and duration while preserving statistical power

    trial design optimizationadaptive simulationBayesian designscost reductionenhanced success probability
  • Adaptive clinical development decisions

    Causal ML‑driven analytics and decision support that enable real‑time evaluation and adjustment of trial parameters, patient stratification, eligibility criteria, and trial response patterns for smarter decision‑making across the clinical lifecycle

    adaptive decisionscausal inferencereal‑time analyticspatient stratificationmulti‑stakeholder insights
  • Closed‑loop trial execution

    Integrated platform capabilities that support end‑to‑end clinical execution — from optimized design through operations with dynamic performance tracking, site selection, and operational guidance — to maintain trial quality, efficiency, and compliance

    closed‑loop executiontrial operationssite selectionperformance monitoringadaptive execution
RankGlobal provider intelligence
Analyst brief

Mapped Evidence Report

A decision-support view of PhaseV, built from mapped taxonomy signals, evidence confidence, commercial profile and reviews.

Primary feed set
Predictive Analytics
Compared with
946 providers
Evidence signals used
3 signals
Publication status
Published
Structured evidence signal
91/100
Strong evidence
58th percentile of 946 peers · peer median 100
Profile coverage100
Taxonomy density75
Review signal100
Peer benchmark
How the profile compares

Predictive Analytics among 946 published providers

Average rating4.87 · median 4.84
Mapped reviews11 · median 10
Profile completeness100% · median 100%
Taxonomy breadth9 · median 20
Signal radar
Multi-dimensional evidence
RatingReviewsCoverageBreadth
This profile (percentile) Peer median
Capability mix
Mapped category signal
Predictive Analytics100%

Imported mapping confidence for each category — not a share of work, revenue, or delivery volume.

Mapped industries
1 industry on the map
1
Healthcare & Life Sciences100%

Share of mapped industry rows on the taxonomy map — not share of work or revenue.

Evidence mix
Mapping grades
Direct56% · 5
Supported33% · 3
Adjacent11% · 1

Imported mapping grades across 9 taxonomy mappings — not a search ranking.

RankGlobal analyst interpretation

What the mapped signals say

PhaseV presents as a strong evidence profile for Predictive Analytics. It ranks in the 58th percentile of 946 published providers in Predictive Analytics, and 11 reviews back the commercial profile.

Current positioning: P58 evidence quality · P1 industry breadth
Strongest signals
Evidence-backed strength in Predictive Analytics is the profile's clearest signal in the mapped taxonomy.
Best user fit
Healthcare & Life Sciences buyers evaluating Predictive Analytics at a $25K - $75K engagement size.
Confirm before engagement
Confirm current delivery capacity directly — mapped signals reflect profile evidence, not live availability.
Client feedback signals
11
Reviews
4.9
Average rating
0
Publicly reshared
Published
Listing status
How this report is calculated →
Industry experience

Where this expertise is most relevant.

Industry mappings are organized by evidence strength so buyers can distinguish demonstrated alignment from broader search relevance.

2 mapped subindustries
Client feedback

What clients say.

Reviews and ratings published for this provider.

Their expertise helped us identify a promising subpopulation that otherwise would not have been detected.

Stu Bailey, D.Phil., SVP Head of Clinical Measurement Sciences
5
Delivering Mathematical Rigor and Code in Multidisciplinary AI Teams

A truly multidisciplinary team delivering both the code and the mathematical rigor required for research.

Innovation Lead
5
Rapid Prototyping of Custom Simulation Platforms for Clinical Rules

Incredible speed. Their team built a custom simulation platform for our escalation rules in just three months.

Senior Scientist
5
Allocating R&D Resources via Data-Driven ROI Roadmaps

Provided a clear ROI roadmap for our pipeline. We now allocate resources based on data rather than intuition.

VP of R&D
5
Verifying Complex Clinical Trial Plans via Integrated AI Assistants

Excellent integration of AI assistants. Simplifies verification of challenging trial plans for clinicians.

Data Manager
5
Reducing Patient Enrollment Requirements by 12% via Adaptive Design

Adaptive design reduced our enrollment requirements by 12% without sacrificing statistical power.

Pharma Partner
5
Aligning Clinical Bayesian Methods with FDA Regulatory Expectations

Their Bayesian methods are perfectly aligned with current FDA regulatory expectations for modern trials.

Reg. Consultant
5
Saving Millions in Capital via Early Identification of Trial Failures

Identified trial failures early, saving millions in capital that would have been wasted on dead-end leads.

Chief Medical Officer
5
Managing Multi-Dose Complexity and Safety Rules in AI Research

The platform's ability to handle multiple doses and complex safety rules is unmatched in the current market.

Senior Statistician

10 mapped reviews · 11 published quotes

Showing 9 of 11, ranked by display order then recency.

Rating distribution
5
10
4
0
3
0
2
0
1
0

Ratings aggregate 11 reviews at the average shown above.

Transparent profile intelligence

How RankGlobal maps this profile.

RankGlobal maps this profile against a controlled taxonomy. Mapping grades on capability and industry cards describe how the profile is classified. Source strength for ranking decisions follows the hierarchy published on Research— a mapping grade is not a claim of discoverability weight.

Tier 1 · Authoritative
Regulators, registries, certifications, signed client evidence.
Highest evidentiary weight
Tier 2 · Independent
Credible media, industry bodies, partner directories, third-party datasets.
Strong with attribution and recency
Tier 3 · Provider-controlled
Company site, case studies, press releases, structured submissions.
Accepted as a claim; verification raises weight
Tier 4 · Discovery-only
Directory listings, aggregations, and early discovery signals.
Used for discovery; weighted accordingly in ranking

Direct, Supported, Related and Adjacent appear on mapped cards as classification grades. They do not rank how discoverable a provider should be.

RankGlobal trust center →
Ready to evaluate this provider

Move from discovery to a focused conversation.

Your enquiry goes to the RankGlobal research team, not the provider's sales inbox. Sending it does not affect their ranking.

Before you reach out

What RankGlobal holds on file for PhaseV, and the three things worth confirming directly once you're in touch.

Primary category
Predictive Analytics
Primary industry
Healthcare & Life Sciences
Typical budget
$25K - $75K
Team size
1-10 employees
  1. 1
    Name the use case

    Say which Predictive Analytics problem you are evaluating, so the research team can route your message accurately.

  2. 2
    Pressure-test the budget band

    The $25K - $75K band on file is a profile-level figure. Ask what a scope like yours actually lands at.

  3. 3
    Ask for a reference

    Request a client reference in Healthcare & Life Sciences — the strongest industry signal on this profile.

Enquire about PhaseV

Three fields. Anything longer belongs on the full contact page, linked below.